Table 1. Characteristics of children in the four study groups.

Characteristics	Placebo n (%)	SP bimonthly n (%)	AS+AQ bimonthly n (%)	AS+AQ monthly n (%)	p-value
Number of children enrolled	650 (26.5)	613 (25.0)	562 (23.0)	626 (25.5)	0.553
Age (in months) (mean, SD)	27.4 (14.9)	27.6 (15.8)	26.8 (15.7)†	27.0 (15.8)	0.002$
3–11	101 (15.5)	124 (20.0)	127 (22.9)	136 (21.6)†	0.007
12–23	193 (29.6)	154 (24.9)	139 (25.1)	161 (25.6)	0.197
24–35	162 (24.9)	123 (19.9)	113 (20.4)	131 (20.8)	0.113
36–47	106 (16.3)	119 (19.2)	104 (18.8)	106 (16.9)	0.453
48–59	86 (13.2)	91 (14.7)	70 (12.6)	93 (14.8)	0.617
Sex (male)	329 (50.6)	301 (49.1)	278 (50.2)	312 (49.8)	0.959
Owns bednet	186 (28.5)	178 (28.8)	169 (30.5)	193 (30.7)	0.780
Owns ITN	90 (13.8)	92 (14.9)	86 (15.5)	95 (15.1)	0.862
Slept under bednet last night	131 (20.1)	119 (19.2)	122 (21.7)	127 (20.3)	0.774
Slept under ITN last night	61 (9.4)	68 (11.0)	67 (12.1)	66 (10.5)	0.497
Stunted	0	1 (0.16)	3 (0.53)	2 (0.3)	0.281*
Wasted	80 (12.3)	61 (10.0)	71 (12.6)	85 (13.6)	0.249
Underweight	186 (28.6)	165 (26.9)	164 (29.2)	179 (28.6)	0.837
MUAC (cm) (mean, SD)	15.5 (1.634)	15.6 (1.554)	15.6 (1.521)	15.5 (1.624)	0.277$
BMI (mean, SD)	0.159 (0.024)	0.160 (0.024)	0.159 (0.026)	0.160 (0.024)	0.999$
G-6-PD Deficient	N = 124 18 (14.5)	N = 139 24 (17.3)	N = 119 20 (16.8)	N = 113 12 (10.6)	0.459
Hb genotype	N = 110	N = 116	N = 98	N = 80
AA	89 (80.9)	70 (60.3)	58 (59.2) †	58 (72.5)	0.001
AS	15 (13.6)	25 (21.2)	16 (16.3)	10 (12.5)	0.289
AC	3 (2.7)	14 (12.1)†	20 (20.4)†	7 (8.6)	0.006*
SC	3 (2.7)	0 (0.0)	3 (3.1)	1 (1.3)	0.283*
CC	0 (0.0)	0 (0.0)	0 (0.0)	3 (3.8)	-
SS	0 (0.0)	7 (6.0)†	1 (1.0)	1 (1.3)	0.011*

^†p <0.05 for the individual intervention group compared to the placebo group

^*Fisher's Exact Test P values

^$ANOVA